fluoxetine has been researched along with carbamazepine in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 20 (21.98) | 18.2507 |
2000's | 18 (19.78) | 29.6817 |
2010's | 48 (52.75) | 24.3611 |
2020's | 5 (5.49) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Bhat, MA; Ehtaishamul Haque, S; Khan, SA; Rana, A; Siddiqui, N | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Sen, S; Sinha, N | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Gernaat, HB; Touw, DJ; van der Woude, J | 1 |
Alarcon, RD; Johnson, BR; Lucas, JP | 1 |
Carter, JG; D'Mello, AP; D'Souza, MJ; Grimsley, SR; Jann, MW | 1 |
Gernaat, HB; Touw, DJ; Van de Woude, J | 1 |
Feder, R | 1 |
Pearson, HJ | 1 |
Bushnell, DL; Hines, ME; Manshadi, FF; Roberts, MA | 1 |
Campbell, M; Cueva, JE | 1 |
Leitner, P; Serfling, R | 1 |
Dursun, SM; Mathew, VM; Reveley, MA | 1 |
Reus, VI | 1 |
Anderson, GD; Gidal, BE; Miyoshi, HR; Seaton, TL; Wilenksy, AJ | 1 |
Avenoso, A; Caputi, AP; Fazio, A; Pisani, F; Pollicino, AM; Spina, E | 1 |
Asnis, J; Patel, SV; Tariot, PN | 1 |
Daniel, WA; Wójcikowski, J | 2 |
Brent, NB; Wisner, KL | 1 |
Boerlin, HL; Gitlin, MJ; Hammen, CL; Zoellner, LA | 1 |
Dailey, JW; Jobe, PC; Milbrandt, JC; Reith, ME; Steidley, KR | 1 |
Björnsdóttir, I; Einarson, A; Einarson, TR; Gerichhausen, S; Koren, G; Lyszkiewicz, DA | 1 |
Jiang, A; LoGrasso, PV; Stearns, BA; Trauger, JW | 1 |
Bocchetta, A; Del Zompo, M; Martinelli, V; Palmas, AM | 1 |
De Lange, HJ; Lürling, M; Murk, AJ; Noordoven, W; Peeters, ET | 1 |
André, C; Blaise, C; Gagné, F; Salazar, M | 1 |
Borowicz, KK; Czuczwar, SJ; Furmanek-Karwowska, K; Luszczki, JJ; Sawicka, K | 1 |
DeLorenzo, ME; Fleming, J | 1 |
Preskorn, SH | 1 |
Ketter, TA | 1 |
Ames, A; Czajkowski, KP; Fang, M; Spongberg, AL; Witter, JD; Wu, C | 1 |
Marilov, VV; Sologub, MB | 1 |
Ford, AT; Guler, Y | 1 |
Halden, RU; McClellan, K; Walters, E | 1 |
Castberg, I; Davies, SJ; Lennard, MS; Lewis, G; Spigset, O; Taylor, S; Westin, AA | 1 |
Luong, D; Metcalfe, CD; Oakes, KD; Pawliszyn, J; Servos, MR; Wen, JZ; Zhang, X | 1 |
Chambers, CD | 1 |
Joshi, PP; Klaper, RD; Thomas, MA | 1 |
Bragg, L; Cui, S; Dixon, DG; Liu, H; Oakes, KD; Ouyang, G; Pawliszyn, J; Servos, MR; Wang, S | 1 |
Bragg, LM; Dixon, G; Oakes, KD; Pawliszyn, J; Servos, MR; Wang, S | 1 |
Oakes, KD; Pawliszyn, J; Servos, MR; Togunde, OP | 1 |
Klaper, RD; Thomas, MA | 1 |
Li, B; Yu, K; Zhang, T | 1 |
Coleman, HM; Khan, SJ; Le-Clech, P; Stuetz, RM; Trinh, T; van den Akker, B | 1 |
Arora, T; Bhowmik, M; Khanam, R; Vohora, D | 1 |
Braitberg, G; Fisher, J; Graudins, A; Taori, G | 1 |
Bergström, E; Boxall, AB; Carter, LJ; Dowle, A; Garman, CD; Ryan, J; Thomas-Oates, J | 1 |
Cardoso, DN; Loureiro, S; Oliveira, M; Soares, AM | 1 |
Prosser, RS; Sibley, PK; Trapp, S | 1 |
Baudot, R; Berlioz-Barbier, A; Buleté, A; Cren-Olivé, C; Garric, J; Gust, M; Wiest, L | 1 |
Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S | 1 |
Gold, PW; Goldstein, SA; Kling, MA; Licinio, J; Michelson, D; Mouro, CM; Pavlatou, MG; Wong, ML | 1 |
Barata, C; Campos, B; Rivetti, C | 1 |
Batley, GE; Hutchinson, TH; Kumar, A; Nidumolu, B | 1 |
Boxall, ABA; Carter, LJ; Ryan, JJ | 1 |
Aho, K; Bearden, S; Finney, B; Huber, DP; Kaushik, G; Thomas, MA; Zarbalis, KS | 1 |
Kaushik, G; Thomas, MA; Xia, Y; Yang, L | 1 |
Benskin, JP; Butler, H; Chandramouli, B; Cosgrove, JR; Helbing, CC; Huang, SSY; Veldhoen, N | 1 |
Kaushik, G; Pfau, JC; Thomas, MA; Xia, Y | 1 |
Lourenço, J; Mendo, S; Ofoegbu, PU; Pestana, JLT; Soares, AMVM | 1 |
Ajaman, M; Ghorbanzadeh, B; Naserzadeh, R | 1 |
Cardoso, DN; Loureiro, S; Oliveira, M; Soares, AMVM | 1 |
Kenda, M; Sollner Dolenc, M; Zore, T | 1 |
Chen, KY; Li, RY | 1 |
Doucette, WJ; Lombardero, LR; Pérez, DJ | 1 |
6 review(s) available for fluoxetine and carbamazepine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Fluoxetine; Humans; Imipramine; Lithium; Mutism; Obsessive-Compulsive Disorder; Phenobarbital; Phenytoin; Phobic Disorders; Schizophrenia; Sleep Wake Disorders; Tranquilizing Agents | 1995 |
[The value of psychopharmacotherapy in the treatment of borderline personality disorder].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Carbamazepine; Fluoxetine; Humans; Psychotropic Drugs | 1993 |
Rational polypharmacy in the treatment of mood disorders.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Thyroid Hormones; Tryptophan | 1993 |
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Topics: Acute Disease; Affect; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Carbonate; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration; Valproic Acid | 2008 |
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins | 2022 |
3 trial(s) available for fluoxetine and carbamazepine
Article | Year |
---|---|
Carbamazepine coadministration with fluoxetine or fluvoxamine.
Topics: Adult; Carbamazepine; Depression; Drug Interactions; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Tonic-Clonic; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged | 1993 |
Bipolar depression and antidepressant-induced mania: a naturalistic study.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Verapamil | 1998 |
[Comparative effectiveness of mood stabilizers in the complex therapy of bulimia nervosa].
Topics: Affect; Antidepressive Agents, Second-Generation; Antimanic Agents; Bulimia Nervosa; Carbamazepine; Cognition; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Lamotrigine; Treatment Outcome; Triazines; Young Adult | 2010 |
82 other study(ies) available for fluoxetine and carbamazepine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation.
Topics: Animals; Anticonvulsants; Benzamides; Benzothiazoles; Central Nervous System Depressants; Chemical and Drug Induced Liver Injury; Liver Function Tests; Male; Mice; Rats; Rats, Wistar; Seizures; Structure-Activity Relationship; Sulfides | 2008 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Parkinsonism following addition of fluoxetine to the treatment with neuroleptics or carbamazepine].
Topics: Adult; Aged; Antipsychotic Agents; Carbamazepine; Dopamine Antagonists; Drug Interactions; Female; Fluoxetine; Humans; Male; Parkinson Disease, Secondary; Serotonin Antagonists | 1992 |
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Paranoid Disorders | 1991 |
Increased carbamazepine plasma concentrations after fluoxetine coadministration.
Topics: Administration, Oral; Adult; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Fluoxetine; Humans; Male | 1991 |
Fluoxetine and parkinsonism in patients taking carbamazepine.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders; Serotonin | 1991 |
Fluoxetine-induced mania.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium | 1990 |
Interaction of fluoxetine with carbamazepine.
Topics: Carbamazepine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged | 1990 |
Neurobehavioural dysfunction following mild traumatic brain injury in childhood: a case report with positive findings on positron emission tomography (PET).
Topics: Accidents, Traffic; Anticonvulsants; Antidepressive Agents, Second-Generation; Brain Concussion; Brain Damage, Chronic; Carbamazepine; Child; Child Behavior Disorders; Electroencephalography; Energy Metabolism; Epilepsy, Post-Traumatic; Fluoxetine; Follow-Up Studies; Humans; Male; Mental Recall; Neurocognitive Disorders; Neuropsychological Tests; Temporal Lobe; Tomography, Emission-Computed; Vasodilator Agents; Verapamil; Whiplash Injuries | 1995 |
Toxic serotonin syndrome after fluoxetine plus carbamazepine.
Topics: Carbamazepine; Drug Interactions; Female; Fluoxetine; Humans; Serotonin; Syndrome | 1993 |
Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide.
Topics: Animals; Carbamazepine; Drug Evaluation, Preclinical; Drug Interactions; Fluoxetine; Humans; In Vitro Techniques; Liver; Male; Microsomes, Liver; Perfusion; Rats; Rats, Sprague-Dawley | 1993 |
L-Deprenyl augmentation of fluoxetine in a patient with Huntington's disease.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Attention; Carbamazepine; Depression; Drug Interactions; Drug Therapy, Combination; Expressed Emotion; Female; Fluoxetine; Humans; Huntington Disease; Impulsive Behavior; Monoamine Oxidase Inhibitors; Movement; Selegiline; Violence | 1996 |
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 1997 |
Interactions between promazine and antidepressants at the level of cellular distribution.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline | 1997 |
Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Female; Fluoxetine; Humans; Infant, Newborn; Milk, Human; Pregnancy; Pregnancy Complications | 1998 |
Carbamazepine-induced release of serotonin from rat hippocampus in vitro.
Topics: Animals; Anticonvulsants; Carbamazepine; Carrier Proteins; Citalopram; Fluoxetine; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Synaptosomes | 1998 |
Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antitrichomonal Agents; Canada; Carbamazepine; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Fluoxetine; Humans; Iceland; Metronidazole; Netherlands; Patient Education as Topic; Pharmacies; Pharmacists; Pregnancy | 2001 |
Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics.
Topics: Anticoagulants; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Contraindications; Drug Interactions; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Phenytoin; Selective Serotonin Reuptake Inhibitors | 2001 |
Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 5-alpha-Dihydroprogesterone; Carbamazepine; Catalysis; Clozapine; Enzyme Activation; Enzyme Inhibitors; Fluoxetine; Flurbiprofen; Humans; Hydroxysteroid Dehydrogenases; Kinetics; Oxidation-Reduction; Pregnanediones; Pregnanolone; Recombinant Fusion Proteins; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Ursodeoxycholic Acid | 2002 |
An interaction between carbamazepine and fluvoxamine.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Middle Aged | 1993 |
Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals.
Topics: Amphipoda; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Behavior, Animal; Carbamazepine; Cetrimonium; Cetrimonium Compounds; Dose-Response Relationship, Drug; Environmental Monitoring; Fluoxetine; Fresh Water; Ibuprofen; Lethal Dose 50; Motor Activity; Surface-Active Agents; Water Pollutants, Chemical | 2006 |
Effects of pharmaceutical products and municipal wastewaters on temperature-dependent mitochondrial electron transport activity in Elliptio complanata mussels.
Topics: Bivalvia; Caffeine; Carbamazepine; Cholestanol; Cotinine; Electron Transport; Fluoxetine; Ibuprofen; Lipid Peroxidation; Mitochondria; Novobiocin; Pharmaceutical Preparations; Sewage; Temperature; Trimethoprim; Xenobiotics | 2006 |
Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Drug Interactions; Drug Synergism; Electroshock; Fluoxetine; Male; Memory; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2007 |
Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta.
Topics: Carbamazepine; Chlorophyta; Clofibric Acid; Diclofenac; Drug Interactions; Fluoxetine; Household Products; Phytoplankton; Simvastatin; Triclosan; Water Pollutants, Chemical | 2008 |
Deconstructing a medication regimen.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid | 2008 |
Dissipation and leaching potential of selected pharmaceutically active compounds in soils amended with biosolids.
Topics: Carbamazepine; Clindamycin; Diltiazem; Diphenhydramine; Environmental Restoration and Remediation; Fluoxetine; Pharmaceutical Preparations; Sewage; Soil Pollutants | 2010 |
Anti-depressants make amphipods see the light.
Topics: Amphipoda; Animals; Antidepressive Agents; Behavior, Animal; Carbamazepine; Diclofenac; Fluoxetine; Male; Serotonin; Swimming; Water Pollutants, Chemical | 2010 |
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
Topics: Antimitotic Agents; Azithromycin; Carbamazepine; Carbanilides; Ciprofloxacin; Diphenhydramine; Doxycycline; Environmental Monitoring; Fluoxetine; Sewage; Soil; Tetracycline; Thiabendazole; Triclosan | 2010 |
Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies.
Topics: Adult; Antidepressive Agents, Second-Generation; Antifungal Agents; Antimalarials; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Clopenthixol; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Fluoxetine; Humans; In Vitro Techniques; Ketoconazole; Male; Methotrimeprazine; Microsomes, Liver; Middle Aged; Paroxetine; Quinidine | 2010 |
Temporal resolution of solid-phase microextraction: measurement of real-time concentrations within a dynamic system.
Topics: Animals; Antidepressive Agents; Carbamazepine; Cattle; Feasibility Studies; Fluoxetine; Reproducibility of Results; Serum Albumin, Bovine; Solid Phase Microextraction; Time Factors | 2010 |
Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antidepressive Agents; Arthritis, Rheumatoid; Carbamazepine; Case-Control Studies; Cohort Studies; Female; Fever; Fluoxetine; Humans; Isoxazoles; Leflunomide; Maternal Exposure; Neural Tube Defects; Physical Examination; Pregnancy; Prospective Studies; Research Design; Teratogens; Tretinoin | 2011 |
Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.
Topics: Animals; Behavior, Animal; Brain; Carbamazepine; Cyclohexanols; Cyprinidae; Female; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Male; Oligonucleotide Array Sequence Analysis; Psychotropic Drugs; Reverse Transcriptase Polymerase Chain Reaction; Venlafaxine Hydrochloride | 2012 |
Sampling-rate calibration for rapid and nonlethal monitoring of organic contaminants in fish muscle by solid-phase microextraction.
Topics: Animals; Atrazine; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Environmental Monitoring; Fluoxetine; Muscles; Oncorhynchus mykiss; Perches; Solid Phase Microextraction; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2011 |
Validation and use of in vivo solid phase micro-extraction (SPME) for the detection of emerging contaminants in fish.
Topics: Animals; Atrazine; Benzhydryl Compounds; Carbamazepine; Diclofenac; Environmental Monitoring; Fishes; Fluoxetine; Gemfibrozil; Ibuprofen; Naproxen; Phenols; Solid Phase Extraction; Solid Phase Microextraction; Waste Disposal, Fluid; Water Pollutants, Chemical | 2011 |
Determination of pharmaceutical residues in fish bile by solid-phase microextraction couple with liquid chromatography-tandem mass spectrometry (LC/MS/MS).
Topics: Animals; Bile; Carbamazepine; Chromatography, Liquid; Cities; Cyprinidae; Drug Residues; Environmental Monitoring; Fluoxetine; Hydrolysis; Muscles; Oncorhynchus mykiss; Ontario; Solid Phase Microextraction; Tandem Mass Spectrometry; Waste Disposal, Fluid | 2012 |
Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.
Topics: Animals; Autistic Disorder; Carbamazepine; Cell Adhesion Molecules; Cyclohexanols; Cyprinidae; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Humans; Microarray Analysis; Nerve Tissue Proteins; Psychotropic Drugs; Receptors, Immunologic; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2012 |
Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography-tandem mass spectrometry without SPE pre-concentration.
Topics: Acyclovir; Benzophenones; Carbamazepine; Chromatography, High Pressure Liquid; Fluconazole; Fluoxetine; Hong Kong; Metronidazole; Parabens; Pharmaceutical Preparations; Ranitidine; Sewage; Solid Phase Extraction; Sunscreening Agents; Tandem Mass Spectrometry | 2012 |
Removal of trace organic chemical contaminants by a membrane bioreactor.
Topics: Amitriptyline; Bioreactors; Carbamazepine; Diazepam; Diclofenac; Fluoxetine; Gemfibrozil; Omeprazole; Organic Chemicals; Pharmaceutical Preparations; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Carbamazepine; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Fluoxetine; Male; Mice; Obsessive-Compulsive Disorder; Oxcarbazepine; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction | 2013 |
Methylene blue used in the treatment of refractory shock resulting from drug poisoning.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidotes; Antipsychotic Agents; Blood Gas Analysis; Blood Pressure; Carbamazepine; Dibenzothiazepines; Electrocardiography; Fluid Therapy; Fluoxetine; Humans; Hypnotics and Sedatives; Hypotension; Male; Methylene Blue; Oxazepam; Quetiapine Fumarate; Shock; Valproic Acid; Vasoconstrictor Agents | 2014 |
Fate and uptake of pharmaceuticals in soil-earthworm systems.
Topics: Adsorption; Animals; Biodegradation, Environmental; Carbamazepine; Diclofenac; Fluoxetine; Lactones; Models, Biological; Oligochaeta; Orlistat; Pharmaceutical Preparations; Porosity; Quantitative Structure-Activity Relationship; Soil; Time Factors; Water | 2014 |
Effects of short-term exposure to fluoxetine and carbamazepine to the collembolan Folsomia candida.
Topics: Animals; Arthropods; Carbamazepine; Cholinesterases; Ecotoxicology; Environmental Monitoring; Escape Reaction; Fluoxetine; Glutathione Transferase; Lipid Peroxidation; Soil Pollutants; Time Factors | 2015 |
Modeling uptake of selected pharmaceuticals and personal care products into food crops from biosolids-amended soil.
Topics: Agriculture; Carbamazepine; Carbanilides; Cimetidine; Cosmetics; Crops, Agricultural; Diphenhydramine; Fluoxetine; Gemfibrozil; Miconazole; Models, Theoretical; Pharmaceutical Preparations; Plant Roots; Plant Shoots; Sewage; Soil Pollutants; Triclosan | 2014 |
MicroQuEChERS-nanoliquid chromatography-nanospray-tandem mass spectrometry for the detection and quantification of trace pharmaceuticals in benthic invertebrates.
Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Chromatography, Liquid; Fluoxetine; Gastropoda; Liquid-Liquid Extraction; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2015 |
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage].
Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Mental Disorders; Risperidone | 2015 |
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Bone and Bones; Bone Density; Carbamazepine; Femur; Fluoxetine; Imipramine; Male; Rats; Rats, Sprague-Dawley; Valproic Acid; X-Ray Microtomography | 2015 |
Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna.
Topics: Animals; Behavior, Animal; Carbamazepine; Chromatography, High Pressure Liquid; Daphnia; Fluoxetine; Light; Propranolol; Reproduction; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Toxicity Tests; Water Pollutants, Chemical | 2016 |
Derivation of water quality guidelines for priority pharmaceuticals.
Topics: Animals; Aquatic Organisms; Carbamazepine; Diclofenac; Fluoxetine; Fresh Water; Guidelines as Topic; Pharmaceutical Preparations; Propranolol; Toxicity Tests, Chronic; Water Pollutants, Chemical; Water Quality | 2016 |
Effects of soil properties on the uptake of pharmaceuticals into earthworms.
Topics: Animals; Carbamazepine; Diclofenac; Fluoxetine; Hydrogen-Ion Concentration; Lactones; Oligochaeta; Orlistat; Pharmaceutical Preparations; Soil; Soil Pollutants; Water | 2016 |
Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Female; Fluoxetine; Intestinal Absorption; Liver; Male; Maternal Exposure; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Placenta; Pregnancy; Psychotropic Drugs; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2016 |
Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders.
Topics: Animals; Autistic Disorder; Carbamazepine; Cell Line, Tumor; Environmental Pollutants; Fluoxetine; Gene Expression Profiling; Humans; Nervous System Diseases; Neuroblastoma; Psychotropic Drugs; Transcriptome; Valproic Acid; Venlafaxine Hydrochloride | 2016 |
A multi-omic approach to elucidate low-dose effects of xenobiotics in zebrafish (Danio rerio) larvae.
Topics: Acetaminophen; Animals; Carbamazepine; Diphenhydramine; Dose-Response Relationship, Drug; Fluoxetine; Larva; Metabolome; Models, Animal; Toxicity Tests; Transcriptome; Water Pollutants, Chemical; Xenobiotics; Zebrafish | 2017 |
Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Brain; Carbamazepine; Environment; Female; Fluoxetine; Gene Expression Profiling; Humans; Maternal Exposure; Nervous System Diseases; Venlafaxine Hydrochloride | 2017 |
Effects of low concentrations of psychiatric drugs (carbamazepine and fluoxetine) on the freshwater planarian, Schmidtea mediterranea.
Topics: Animals; Antidepressive Agents, Second-Generation; Carbamazepine; Fluoxetine; Fresh Water; Planarians | 2019 |
Pharmacological evaluation of NO/cGMP/KATP channels pathway in the antidepressant-like effect of carbamazepine in mice.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Carbamazepine; Cyclic GMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; KATP Channels; Locomotion; Male; Mice; Nitric Oxide; Swimming | 2021 |
Susceptibility of Folsomia candida to Agrochemicals after Multigenerational Exposure to Human Pharmaceuticals.
Topics: Agrochemicals; Animals; Arthropods; Carbamazepine; Copper; Dimethoate; Fluoxetine; Humans; Pharmaceutical Preparations; Reproduction; Soil; Soil Pollutants | 2022 |
Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Topics: Androgens; Animals; Carbamazepine; Central Nervous System Agents; CHO Cells; Clonazepam; Cricetinae; Cricetulus; Estrogen Receptor alpha; Estrogens; Fluoxetine; Glucocorticoids; Luciferases, Firefly; Paroxetine; Receptors, Androgen; Receptors, Glucocorticoid; Sertraline; Thyroid Gland | 2022 |
Influence of exposure time, physicochemical properties, and plant transpiration on the uptake dynamics and translocation of pharmaceutical and personal care products in the aquatic macrophyte Typha latifolia.
Topics: Carbamazepine; Chromatography, Liquid; Cosmetics; Fluoxetine; Gemfibrozil; Pharmaceutical Preparations; Plant Transpiration; Tandem Mass Spectrometry; Triclosan; Typhaceae; Water Pollutants, Chemical | 2023 |